Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy
Launched by UNIVERSITY OF PALERMO · Jun 12, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the long-term effects of two different types of hysterectomy surgeries—total hysterectomy (where the entire uterus and cervix are removed) and subtotal hysterectomy (where the uterus is removed but the cervix is kept)—on women who have had the surgery for non-cancerous conditions. The goal is to understand how these surgeries can affect women's sexual health, urinary function, and whether they may experience issues with pelvic organ prolapse (when organs like the bladder or uterus bulge into the vagina) over time.
To participate in the study, women aged between 65 and 74 who have undergone either a total or subtotal hysterectomy using a minimally invasive technique called laparoscopy for benign reasons may be eligible. It’s important to note that women with any type of cancer will not be included in this trial. If you join the study, you can expect to share your experiences regarding any changes in your health after the surgery, which will help researchers better understand the outcomes of these procedures.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women who underwent subtotal or total hysterectomy by laparoscopy for benign conditions.
- Exclusion Criteria:
- • Women with gynecological and non-gynecological cancers.
About University Of Palermo
The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Antonio Simone Laganà, M.D., Ph.D.
Principal Investigator
University of Palermo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials